Report additional data from the CTX110 trial
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 16 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- Q4 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company expects to report additional data from this trial in 2021.”
What we found
Evidence strength A What the grades mean
Later 10-K and 10-Q filings state that updated clinical data from the CARBON trial of CTX110 for 26 patients were released in Q4 2021, before the deadline.
-
A Crispr Therapeutics AG 8-K filed 2022-02-15
“The Company expects to report additional data in 2022.” ✓ confirmed on the page
-
A Crispr Therapeutics AG 10-K filed 2022-02-15
“In the fourth quarter of 2021, we released updated clinical data from the ongoing CARBON trial for 26 patients treated with CTX110 who had reached at least 28 days of follow-up.” ✓ confirmed on the page
-
A Crispr Therapeutics AG 10-Q filed 2022-05-09
“In the fourth quarter of 2021, we released updated clinical data from the ongoing CARBON trial for 26 patients treated with CTX110 who had reached at least 28 days of follow-up.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Additional data from CTX110 trial
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Crispr Therapeutics AG? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CRSP-023937 · Corrections policy